AAAAAA
Results:
1-20
|
Results: 20
Authors:
Mellembakken, JR
Solum, NO
Ueland, T
Videm, V
Aukrust, P
Citation: Jr. Mellembakken et al., Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia - Possible role of platelet activation, THROMB HAEM, 86(5), 2001, pp. 1272-1276
Authors:
Scholz, T
Solberg, R
Okkenhaug, C
Videm, V
Gallimore, MJ
Mathisen, O
Pedersen, T
Mollnes, TE
Bergan, A
Soreide, O
Klintmalm, GB
Aasen, AO
Citation: T. Scholz et al., Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model, PERFUSION-U, 16(4), 2001, pp. 285-292
Authors:
Mellembakken, JR
Aukrust, P
Hestdal, K
Ueland, T
Abyholm, T
Videm, V
Citation: Jr. Mellembakken et al., Chemokines and leukocyte activation in the fetal circulation during preeclampsia, HYPERTENSIO, 38(3), 2001, pp. 394-398
Authors:
Mellembakken, JR
Hogasen, K
Mollnes, TE
Hack, CE
Abyholm, T
Videm, V
Citation: Jr. Mellembakken et al., Increased systemic activation of neutrophils but not complement in preeclampsia, OBSTET GYN, 97(3), 2001, pp. 371-374
Authors:
Odegard, A
Lundbom, J
Myhre, HO
Hatlinghus, S
Bergh, K
Waage, A
Bjerve, KS
Mollnes, TE
Aadahl, P
Lie, TA
Videm, V
Citation: A. Odegard et al., The inflammatory response following treatment of abdominal aortic aneurysms: a comparison between open surgery and endovascular repair, EUR J VAS E, 19(5), 2000, pp. 536-544
Authors:
Videm, V
Svennevig, JL
Fosse, E
Mohr, B
Aasen, AO
Citation: V. Videm et al., Plasma endotoxin concentrations during cardiac surgery may be related to atherosclerosis, PERFUSION-U, 15(5), 2000, pp. 421-426
Authors:
Bergseth, G
Lappegard, KT
Videm, V
Mollnes, TE
Citation: G. Bergseth et al., A novel enzyme immunoassay for plasma thrombospondin: Comparison with beta-thromboglobulin as platelet activation marker in vitro and in vivo, THROMB RES, 99(1), 2000, pp. 41-50
Authors:
Fiane, AE
Videm, V
Lambris, JD
Geiran, OR
Svennevig, JL
Mollnes, TE
Citation: Ae. Fiane et al., Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model, TRANSPLAN P, 32(5), 2000, pp. 899-900
Authors:
Western, KH
Videm, V
Citation: Kh. Western et V. Videm, Donor neutrophil function after plateletpheresis, TRANSFUSION, 40(11), 2000, pp. 1414-1418
Authors:
Hjelde, A
Brubakk, AO
Bergh, K
Videm, V
Ustad, AL
Citation: A. Hjelde et al., Effect of anti-C5a antibody on blood-lung and blood-brain barrier in rabbits after decompression, UNDERS HYP, 26(4), 1999, pp. 249-256
Authors:
Fiane, AE
Videm, V
Mollnes, TE
Hogasen, K
Hovig, T
Citation: Ae. Fiane et al., Inhibition of platelet aggregation by the GPIIb/IIIa antagonist Reopro does not significantly prolong xenograft survival in an ex vivo model, TRANSPLAN I, 12(5), 1999, pp. 323-333
Authors:
Fiane, AE
Mollnes, TE
Videm, V
Hovig, T
Hogasen, K
Mellbye, OJ
Spruce, L
Moore, WT
Sahu, A
Lambris, JD
Citation: Ae. Fiane et al., Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts, XENOTRANSPL, 6(1), 1999, pp. 52-65
Authors:
Mollnes, TE
Videm, V
Christiansen, D
Bergseth, G
Riesenfeld, J
Hovig, T
Citation: Te. Mollnes et al., Platelet compatibility of an artificial surface modified with functionallyactive heparin, THROMB HAEM, 82(3), 1999, pp. 1132-1136
Authors:
Baksaas, ST
Flom-Halvorsen, HI
Ovrum, E
Videm, V
Mollnes, TE
Brosstad, F
Svennevig, JL
Citation: St. Baksaas et al., Leucocyte filtration during cardiopulmonary reperfusion in coronary arterybypass surgery, PERFUSION-U, 14(2), 1999, pp. 107-117
Authors:
Baksaas, ST
Videm, V
Pedersen, T
Karlsen, H
Mollnes, TE
Brosstad, F
Svennevig, JL
Citation: St. Baksaas et al., Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices, PERFUSION-U, 14(2), 1999, pp. 119-127
Authors:
Baksaas, ST
Videm, V
Fosse, E
Karlsen, H
Pedersen, T
Mollnes, TE
Hagve, TA
Svennevig, JL
Citation: St. Baksaas et al., In vitro evaluation of new surface coatings for extracorporeal circulation, PERFUSION-U, 14(1), 1999, pp. 11-19
Authors:
Fiane, AE
Videm, V
Johansen, HT
Mellbye, OJ
Nielsen, EW
Mollness, TE
Citation: Ae. Fiane et al., Cl-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model, IMMUNOPHARM, 42(1-3), 1999, pp. 231-243
Authors:
Fiane, AE
Mollnes, TE
Videm, V
Hovig, T
Hogasen, K
Mellbye, OJ
Spruce, L
Moore, WT
Sahu, A
Lambris, JD
Citation: Ae. Fiane et al., Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor compstatin, TRANSPLAN P, 31(1-2), 1999, pp. 934-935
Authors:
Videm, V
Mollnes, TE
Fosse, E
Mohr, B
Bergh, K
Hagve, TA
Aasen, AO
Svennevig, JL
Citation: V. Videm et al., Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population, J THOR SURG, 117(4), 1999, pp. 794-802
Authors:
Videm, V
Mollnes, TE
Bergh, K
Fosse, E
Mohr, B
Hagve, TA
Aasen, AO
Svennevig, JL
Citation: V. Videm et al., Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo, J THOR SURG, 117(4), 1999, pp. 803-809
Risultati:
1-20
|